{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T19:24:08Z","timestamp":1761765848229,"version":"3.40.5"},"reference-count":30,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","goldjournal.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urology"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.urology.2014.07.072","type":"journal-article","created":{"date-parts":[[2014,11,11]],"date-time":"2014-11-11T16:48:34Z","timestamp":1415724514000},"page":"85-91","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Impact of the 2012 United States Preventive Services Task Force Statement on Prostate-specific Antigen Screening: Analysis of Urologic and Primary Care Practices"],"prefix":"10.1016","volume":"85","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5835-0850","authenticated-orcid":false,"given":"Tomy Y.","family":"Perez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew R.","family":"Danzig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rashed A.","family":"Ghandour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ketan K.","family":"Badani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitchell C.","family":"Benson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James M.","family":"McKiernan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.urology.2014.07.072_bib1","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1001\/jama.1995.03520310046028","article-title":"The role of increasing detection in the rising incidence of prostate cancer","volume":"273","author":"Potosky","year":"1995","journal-title":"JAMA"},{"key":"10.1016\/j.urology.2014.07.072_bib2","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1056\/NEJMoa0810696","article-title":"Mortality results from a randomized prostate-cancer screening trial","volume":"360","author":"Andriole","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.urology.2014.07.072_bib3","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1056\/NEJMoa0810084","article-title":"Screening and prostate-cancer mortality in a randomized European study","volume":"360","author":"Schroder","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.urology.2014.07.072_bib4","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1056\/NEJMoa1113162","article-title":"Radical prostatectomy versus observation for localized prostate cancer","volume":"367","author":"Wilt","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.urology.2014.07.072_bib5","doi-asserted-by":"crossref","first-page":"120","DOI":"10.7326\/0003-4819-157-2-201207170-00459","article-title":"Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement","volume":"157","author":"Moyer","year":"2012","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.urology.2014.07.072_bib6","doi-asserted-by":"crossref","first-page":"185","DOI":"10.7326\/0003-4819-149-3-200808050-00008","article-title":"Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement","volume":"149","year":"2008","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.urology.2014.07.072_bib7","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1001\/archinternmed.2012.3726","article-title":"Impact of 2008 US Preventative Services Task Force recommendation to discontinue prostate cancer screening among male Medicare beneficiaries","volume":"172","author":"Ross","year":"2012","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.urology.2014.07.072_bib8","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1093\/jnci\/djt039","article-title":"Prostate-specific antigen testing in men aged 40-64 years: impact of publication of clinical trials","volume":"105","author":"Goodwin","year":"2013","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.urology.2014.07.072_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.urolonc.2013.04.013","article-title":"Primary care physician\u00a0PSA screening practices before and after the final U.S. Preventative Services Task Force recommendation","volume":"32","author":"Cohn","year":"2014","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urology.2014.07.072_bib10","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1093\/jnci\/djj131","article-title":"Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial","volume":"98","author":"Thompson","year":"2006","journal-title":"JNCI"},{"key":"10.1016\/j.urology.2014.07.072_bib11","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1001\/jama.280.11.969","article-title":"Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer","volume":"280","author":"D'Amico","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.urology.2014.07.072_bib12","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1370\/afm.1445","article-title":"Primary care physicians' use of an informed decision-making process for prostate cancer screening","volume":"11","author":"Volk","year":"2013","journal-title":"Ann Fam Med"},{"key":"10.1016\/j.urology.2014.07.072_bib13","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/pcan.2011.59","article-title":"PSA screening: determinants of primary-care physician practice patterns","volume":"15","author":"Tasian","year":"2012","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.urology.2014.07.072_bib14","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/bju.12029","article-title":"Impact of the European Randomized Study of Screening for Prostate Cancer (ERSPC) on prostate-specific antigen (PSA) testing by Dutch general practitioners","volume":"112","author":"Van der Meer","year":"2013","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2014.07.072_bib15","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1001\/archinternmed.2012.135","article-title":"Primary care providers' response to the US Preventative Services Task Force draft recommendations on screening for prostate cancer","volume":"172","author":"Pollack","year":"2012","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.urology.2014.07.072_bib16","unstructured":"American Urological Assoication. AUA Disputes Panel's Recommendations on Prostate Cancer Screening. Atlanta: PR Newswire, May 21, 2012. Web. May 24, 2014.\u00a0http:\/\/www.prnewswire.com\/news-releases\/aua-disputes-panels-recommendations-on-prostate-cancer-screening-152349275.html. Accessed October 20, 2014."},{"key":"10.1016\/j.urology.2014.07.072_bib17","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.3109\/0284186X.2012.762998","article-title":"Factors influencing primary\u00a0care physicians' decision to order prostate-specific antigen (PSA) test for men without prostate cancer","volume":"52","author":"Roshanai","year":"2013","journal-title":"Acta Oncol"},{"key":"10.1016\/j.urology.2014.07.072_bib18","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.urology.2006.12.014","article-title":"PCA3 molecular urine assay for prostate cancer in men undergoing repeat biopsy","volume":"69","author":"Marks","year":"2007","journal-title":"Urology"},{"key":"10.1016\/j.urology.2014.07.072_bib19","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.eururo.2008.06.071","article-title":"Clinical utility of the PCA3 urine assay in European men scheduled for repeat biopsy","volume":"54","author":"Haese","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2014.07.072_bib20","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/pros.22538","article-title":"Use of PCA3 in detecting prostate cancer in initial and repeat prostate biopsy patients","volume":"73","author":"Goode","year":"2013","journal-title":"Prostate"},{"key":"10.1016\/j.urology.2014.07.072_bib21","first-page":"2119","article-title":"Clinical evaluation of the PCA3 assay in guiding initial biopsy decisions","volume":"185","author":"de la Taille","year":"2011","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.urology.2014.07.072_bib22","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.eururo.2010.10.039","article-title":"EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease","volume":"59","author":"Heidenreich","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2014.07.072_bib23","unstructured":"NCCN Guidelines. Prostate cancer early detection [v.2.2012]. National Comprehensive Cancer Network Web site. http:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/prostate_detection.pdf."},{"key":"10.1016\/j.urology.2014.07.072_bib24","doi-asserted-by":"crossref","first-page":"d7894","DOI":"10.1136\/bmj.d7894","article-title":"Short term outcomes of prostate biopsy in men tested for cancer by prostate specific antigen: prospective evaluation within ProtecT study","volume":"344","author":"Rosario","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.urology.2014.07.072_bib25","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/j.1464-410X.2006.06388.x","article-title":"African-American race is\u00a0a predictor of prostate cancer detection: incorporation into a pre-biopsy nomogram","volume":"98","author":"Yanke","year":"2006","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2014.07.072_bib26","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1093\/jnci\/djq265","article-title":"Effects of prostate-specific antigen testing on familial prostate cancer risk estimates","volume":"102","author":"Bratt","year":"2010","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.urology.2014.07.072_bib27","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1056\/NEJMoa0908127","article-title":"Effect of dutasteride on the risk of prostate cancer","volume":"362","author":"Andriole","year":"2010","journal-title":"N\u00a0Engl J\u00a0Med"},{"key":"10.1016\/j.urology.2014.07.072_bib28","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/S0090-4295(03)00108-0","article-title":"Prospective evaluation of a 21-sample needle biopsy procedure designed to improve the prostate cancer detection rate","volume":"61","author":"de la Taille","year":"2003","journal-title":"Urology"},{"key":"10.1016\/j.urology.2014.07.072_bib29","first-page":"63","article-title":"Impact of increased number of biopsies on the nature of prostate cancer identified","volume":"176","author":"Meng","year":"2006","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.urology.2014.07.072_bib30","first-page":"419","article-title":"Early detection of prostate cancer: AUA Guideline","volume":"190","author":"Carter","year":"2013","journal-title":"J\u00a0Urol"}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009042951400990X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009042951400990X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,27]],"date-time":"2018-09-27T17:21:49Z","timestamp":1538068909000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009042951400990X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["S009042951400990X"],"URL":"https:\/\/doi.org\/10.1016\/j.urology.2014.07.072","relation":{},"ISSN":["0090-4295"],"issn-type":[{"type":"print","value":"0090-4295"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of the 2012 United States Preventive Services Task Force Statement on Prostate-specific Antigen Screening: Analysis of Urologic and Primary Care Practices","name":"articletitle","label":"Article Title"},{"value":"Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urology.2014.07.072","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}